Telemedicine Market is Ought to Grow at Phenomenal Double-Digit CAGR of 16.8% During Forecast 2017-2023

Market Scenario:
The global telemedicine market is presumed to garner USD 56,738.3 during the forecast period (2017-2023). The market is expected to project 16.8% CAGR owing to the prevalence of chronic diseases, asserts Market Research Future (MRFR). Telemedicine is referred to as the remote delivery of healthcare services like consultations over teleconference or telecommunication, which enables healthcare professionals to diagnose, evaluate, and treat patients. It serves as a provision for several remote clinical services which helps in the two-way communication between the patient and healthcare provider.
With the increasing adoption of electronic medical record and electronic health record, the global telemedicine market is likely to flourish during the assessment period. Growing incidences of chronic diseases such as cancer and diabetes coupled with the increasing demand for improving the healthcare services are boosting the market. Healthcare organizations are also adopting digital healthcare platforms in order to enable remote monitoring of the patients.
Access Full Report Details With PDF and Infographics Illustration Exclusively @ https://www.marketresearchfuture.com/reports/telemedicine-market-2216
Competitive Dashboard:
·         Iris Telehealth
·         Cardiocom
·         AMD Global Telemedicine Inc
·         Cisco
·         Aerotel Medical Systems Ltd
·         Cerner Corporation
·         Tunstall Healthcare
·         Honeywell Lifesciences
·         CareClix
·         GENERAL ELECTRIC
·         Care Innovations
·         CardioNet,
Segmental Analysis:
·         The telemedicine market is segmented on the basis of component, service type, application, deployment, end-user, and region.
·         By mode of service type, the global telemedicine market has been segmented into telepharmacy, telenursing, teledermatology, teleradiology, tele-oncology, and others.
·         By mode of component, the global telemedicine market has been segmented into hardware and software. Among these, the software segment has been sub-segmented into standalone software and integrated software. The hardware segment has been sub-segmented into medical peripheral devices and monitors.
·         By mode of deployment, the global telemedicine market has been segmented into on-premise and cloud-based. Among these, the cloud-based deployment holds the major market share and is estimated to maintain its dominance over the forecast period.
·         By mode of application, the global telemedicine market has been segmented into ophthalmology, cardiology, radiology, psychiatry, dermatology, and others.
·         By mode of end-users, the global telemedicine market has been segmented into homecare, hospitals, and clinics.
Regional Insights:
Geographically, the telemedicine market span across regions namely, America, Europe, Asia Pacific, and the Middle East and Africa.
Among all the regions, America is considered to dominate the global telemedicine market owing to the increased adoption of healthcare IT and a well-developed healthcare sector in this region. Also, the presence of major market players coupled with increasing expenditure on healthcare is considered to stimulate the market growth in this region.
Europe holds the second position due to the rising adoption of latest technologies along with growing government support to address the healthcare demands. The Asia Pacific region is the fastest growing region owing to the presence of huge patient population. Also, with the expanding telemedicine sector, the market is likely to flourish in this region. Also, the presence of developing countries such as Australia, India, and China are expected to augment the growth of the market.
Industry Updates:
November 08, 2018: A leading owner and operator of medical cannabis and wellness clinics in the US, Empower Clinics Inc, has recently announced that it is completing a telemedicine platform that will allow interested patients across the globe to connect with its specialized medical doctors.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more